KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Change in Inventory (2016 - 2025)

Resmed (RMD) has disclosed Change in Inventory for 17 consecutive years, with -$26.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 441.96% year-over-year to -$26.1 million, compared with a TTM value of -$9.2 million through Dec 2025, up 46.58%, and an annual FY2025 reading of $80.2 million, up 146.55% over the prior year.
  • Change in Inventory was -$26.1 million for Q4 2025 at Resmed, down from $14.7 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $147.1 million in Q3 2022 and bottomed at -$86.2 million in Q1 2024.
  • Average Change in Inventory over 5 years is $22.2 million, with a median of $14.4 million recorded in 2021.
  • The sharpest move saw Change in Inventory soared 557.95% in 2021, then crashed 492.26% in 2024.
  • Year by year, Change in Inventory stood at $83.3 million in 2021, then increased by 3.3% to $86.0 million in 2022, then plummeted by 158.34% to -$50.2 million in 2023, then surged by 115.23% to $7.6 million in 2024, then plummeted by 441.96% to -$26.1 million in 2025.
  • Business Quant data shows Change in Inventory for RMD at -$26.1 million in Q4 2025, $14.7 million in Q3 2025, and $32.1 million in Q2 2025.